- CDDO and Its Role in Chronic Diseases
Bryan J. Mathis et al, 2016, Drug Discovery from Mother Nature CrossRef - Synthetic oleanane triterpenoid derivative CDDO‐Me disrupts cellular bioenergetics to suppress pancreatic ductal adenocarcinoma via targeting SLC1A5
Percy D. P. Akuetteh et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef - NOX2-ROS-HIF-1α signaling is critical for the inhibitory effect of oleanolic acid on rectal cancer cell proliferation
Yongfeng Guo et al, 2017, Biomedicine & Pharmacotherapy CrossRef - The role of natural products in revealing NRF2 function
Donna D. Zhang et al, 2020, Natural Product Reports CrossRef - Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells
Abdullah Shopit et al, 2021, Phytomedicine CrossRef - Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase
Songting Shou et al, 2024, Cancer Gene Therapy CrossRef - Molecular Repolarisation of Tumour-Associated Macrophages
Floris van Dalen et al, 2018, Molecules CrossRef - The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis
Christopher J. Occhiuto et al, 2023, Molecules and Cells CrossRef - Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment
Jorge A.R. Salvador et al, 2017, European Journal of Medicinal Chemistry CrossRef - Location, Orientation and Aggregation of Bardoxolone-ME, CDDO-ME, in a Complex Phospholipid Bilayer Membrane
Vicente Galiano et al, 2020, The Journal of Membrane Biology CrossRef - Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
Emiliano Panieri et al, 2021, Antioxidants & Redox Signaling CrossRef - Prophylactic and therapeutic roles of oleanolic acid its derivatives in several diseases
Alaattin Sen, 2020, World Journal of Clinical Cases CrossRef